Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

AMC Is Worth a Good Deal More at $58, Present Losses or Not

By Mark R. Hake, CFA

AMC stock is still worth more, despite its present losses. AMC is worth some 32% more because it could eventually make positive FCF.

Oracle Remains a Free Cash Flow Powerhouse

By Mark R. Hake, CFA

Oracle remains a free cash flow powerhouse. Its FCF this year could lead to a minimum expected return for ORCL stock of about 15%.

Powerful Free Cash Flow Could Push Amazon Over $4,000 Per Share

By Mark R. Hake, CFA

Amazon's powerful FCF could push AMZN stock higher. It is worth $4,012 per share based on its average FCF margins and sales estimates for 2022.

FuboTV Is Set to Climb Higher as Its Subscribers and Revenue Grow

By Mark R. Hake, CFA

FuboTV is set to move higher as subscribers and ARPU grow. As revenue and FCF climb, FUBO stock is likely to rise over 45% in the next year.

Ocugen Should Hit $9 If Its Covid-19 Vaccine Gets Approved

By Mark R. Hake, CFA

Ocugen still hopes its Covid-19 vaccine gets approved to start making revenue. OCGN-stock could be worth as much as $9.09 or 19% over today's price assuming its Covid-19 vaccine gets approval.

Cardano’s Recent Spike Makes It the 3rd Largest Crypto, But There Could Be More

By Mark R. Hake, CFA

Cardano's recent spike makes it the 3rd largest crypto, but it could have further to go. Cardano could still rise another 23% to $3.44 or so over the next year if it gains a significant market share in smart contracts.

GE Stock Could Be a Turnaround Story With an Eye on $150

By Mark R. Hake, CFA

Looking at the latest earnings, GE could make a 6% FCF margin, valuing GE stock with a 3% FCF yield, pushing it 43% higher.

Massive Free Cash Flow Makes Undervalued Robinhood Stock Attractive

By Mark R. Hake, CFA

Robinhood profits could take longer than previously expected, but HOOD stock could still be undervalued. It is expensive on a P/E basis, but from an FCF standpoint, it is undervalued and worth nearly $67 over the next year.

Tattooed Chef Needs to Profit Before Its Shares Can Move

By Mark R. Hake, CFA

Don't expect Tattooed Chef to turn around until it can produce profits. TTCF stock is likely to trade in a range around its price today as long as the company does not produce profits.

Opendoor Technologies Still Looks Quite Undervalued Now With Profitable Operations

By Mark R. Hake, CFA

Opendoor Technologies still looks quite undervalued now. OPEN stock will rise 10% to 24% given that it has positive adj. EBITDA profits.

Load More